BRPI0818009A2 - Antagonistas de glicosaminoglicano com base em sdf-1 e métodos para usar os mesmos - Google Patents

Antagonistas de glicosaminoglicano com base em sdf-1 e métodos para usar os mesmos

Info

Publication number
BRPI0818009A2
BRPI0818009A2 BRPI0818009A BRPI0818009A2 BR PI0818009 A2 BRPI0818009 A2 BR PI0818009A2 BR PI0818009 A BRPI0818009 A BR PI0818009A BR PI0818009 A2 BRPI0818009 A2 BR PI0818009A2
Authority
BR
Brazil
Prior art keywords
sdf
antagonists
methods
glycosaminoglycan
based glycosaminoglycan
Prior art date
Application number
Other languages
English (en)
Portuguese (pt)
Inventor
Andreas Kungl
Isa Werner
Jason Slingsby
Simi Ali
John A Kirby
Original Assignee
Protaffin Biotechnologie Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Protaffin Biotechnologie Ag filed Critical Protaffin Biotechnologie Ag
Publication of BRPI0818009A2 publication Critical patent/BRPI0818009A2/pt

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/52—Cytokines; Lymphokines; Interferons
    • C07K14/521—Chemokines
    • C07K14/522—Alpha-chemokines, e.g. NAP-2, ENA-78, GRO-alpha/MGSA/NAP-3, GRO-beta/MIP-2alpha, GRO-gamma/MIP-2beta, IP-10, GCP-2, MIG, PBSF, PF-4, KC
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/04—Antineoplastic agents specific for metastasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Zoology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Toxicology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Oncology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
BRPI0818009 2007-10-24 2008-10-23 Antagonistas de glicosaminoglicano com base em sdf-1 e métodos para usar os mesmos BRPI0818009A2 (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP07450189A EP2053060A1 (en) 2007-10-24 2007-10-24 SDF-1-based glyocosaminoglycan antagonists and methods of using same
PCT/EP2008/008960 WO2009053064A1 (en) 2007-10-24 2008-10-23 Sdf-1-based glycosaminoglycan antagonists and methods of using same

Publications (1)

Publication Number Publication Date
BRPI0818009A2 true BRPI0818009A2 (pt) 2015-04-14

Family

ID=39133777

Family Applications (1)

Application Number Title Priority Date Filing Date
BRPI0818009 BRPI0818009A2 (pt) 2007-10-24 2008-10-23 Antagonistas de glicosaminoglicano com base em sdf-1 e métodos para usar os mesmos

Country Status (13)

Country Link
US (1) US20100298203A1 (cg-RX-API-DMAC7.html)
EP (2) EP2053060A1 (cg-RX-API-DMAC7.html)
JP (1) JP2011501675A (cg-RX-API-DMAC7.html)
KR (1) KR20100085041A (cg-RX-API-DMAC7.html)
CN (1) CN101835800A (cg-RX-API-DMAC7.html)
AU (1) AU2008315614A1 (cg-RX-API-DMAC7.html)
BR (1) BRPI0818009A2 (cg-RX-API-DMAC7.html)
CA (1) CA2702502A1 (cg-RX-API-DMAC7.html)
EA (1) EA201000688A1 (cg-RX-API-DMAC7.html)
IL (1) IL205300A0 (cg-RX-API-DMAC7.html)
MX (1) MX2010004025A (cg-RX-API-DMAC7.html)
NZ (1) NZ584278A (cg-RX-API-DMAC7.html)
WO (1) WO2009053064A1 (cg-RX-API-DMAC7.html)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2010294225A1 (en) * 2009-09-11 2012-04-05 Protaffin Biotechnologie Ag Composition for treatment of CXCL8-mediated lung inflammation
CN102094043B (zh) * 2010-11-23 2012-11-07 山东农业大学 猪趋化因子cxcl12基因及其应用
EP2686344A1 (en) 2011-03-16 2014-01-22 Protaffin Biotechnologie AG Fgfr1-based antagonists with improved glycosaminoglycan affinity and methods of using same
EP2729487A2 (en) 2011-07-08 2014-05-14 Protaffin Biotechnologie AG Novel sdf-1-based glycosaminoglycan antagonist and methods of using same

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5364894A (en) * 1993-03-31 1994-11-15 Tremco, Inc. Emulsification of asphalt and modified asphalt with primary emulsifier polymers comprised of acrylic acid type monomers
WO1997037005A1 (en) * 1996-04-02 1997-10-09 Progenics Pharmaceuticals, Inc. Method for preventing hiv-1 infection of cd4+ cells
ATE265219T1 (de) * 2000-05-09 2004-05-15 Univ British Columbia Verwendung von cxcr4 antagonisten zur behandlung von krebs und autoimmunkrankheiten
WO2004094465A2 (en) * 2003-04-23 2004-11-04 The Board Of Trustees Of The University Of Illinois Office Of Technology Management University Of Illinois At Urbana-Champaign Synthetic molecules that mimic chemokines
AT412785B (de) * 2003-12-04 2005-07-25 Kungl Andreas J Dr Gag-bindungsproteine
US7662221B2 (en) * 2006-06-23 2010-02-16 Johns Manville Spray applied building wrap coating material, spray applied building wrap, and building construction assembly
AT504685B1 (de) * 2006-12-20 2009-01-15 Protaffin Biotechnologie Ag Fusionsproteine

Also Published As

Publication number Publication date
IL205300A0 (en) 2010-12-30
KR20100085041A (ko) 2010-07-28
JP2011501675A (ja) 2011-01-13
EP2203473A1 (en) 2010-07-07
AU2008315614A1 (en) 2009-04-30
NZ584278A (en) 2012-06-29
EA201000688A1 (ru) 2010-10-29
WO2009053064A8 (en) 2009-07-16
CN101835800A (zh) 2010-09-15
MX2010004025A (es) 2010-04-30
CA2702502A1 (en) 2009-04-30
WO2009053064A1 (en) 2009-04-30
US20100298203A1 (en) 2010-11-25
EP2053060A1 (en) 2009-04-29

Similar Documents

Publication Publication Date Title
BRPI0717638A2 (pt) Anticorpors e imunoconjugados e usos para os mesmos
BRPI1008020A2 (pt) antagonistas e agonistas inversos h3 da histamina e métodos de uso dos mesmos
BRPI0813216A2 (pt) Inibidores de proteínas cinases e métodos para usá-los.
HRP20151108T1 (xx) Antagonisti nogo-receptora
BRPI0717389A2 (pt) Dispositivos e métodos para avanço de stent
DK2094709T3 (da) Thiazol-pyrazolopyrimidiner som CRF1-receptorantagonister
DK2049478T3 (da) Substituerede N-phenylmethyl-5-oxoprolin-2-amider som P2X7-receptorantagonister og fremgangsmåder til anvendelse deraf
BRPI0815043A2 (pt) mcp-1 mutantes antagonistas de glicosaminoglicanos e métodos para o seu uso
BRPI0816063A2 (pt) Garrafas retráteis e métodos para uso do mesmo
DK1999154T3 (da) Fremstillede heterodimere proteindomæner
BRPI0809931A2 (pt) Antagonistas do receptor do hormônio liberador de gonadotrofina e métodos relacionados com o mesmo
EP2215246A4 (en) PROTEIN SCAFFOLDS
ATE479434T1 (de) Als protein-kinase-inhibitoren nutzbare dyhydrodiazepine
BRPI0819911A2 (pt) composições compreendendo agonistas nicotínicos e métodos para usar as mesmas
HRP20170218T1 (hr) Sferični blok za čišćenje wc-a, postupak za proizvodnju istog, i nosač koji obuhvaća sferične blokove za čišćenje wc-a
BRPI0820114A2 (pt) Engenharia de proteínas enzimaticamente suscetíveis
DE502007001122D1 (de) Humeruskomponente
BRPI0718166A2 (pt) Distribuidor para intalações insufladoras, alto-fornos e similares unidades
BRPI0917564A2 (pt) bioensaio para proteína poli-q
BRPI1006857A2 (pt) agentes de limpeza para limpeza de poços e métodos de uso dos mesmos
DK2139890T3 (da) Perifere opioidreceptor-antagonister og anvendelser deraf
BRPI0907236A2 (pt) inibidores de proteína quinase e uso dos mesmos
BRPI0716794A2 (pt) articulaÇço esfÉrica
ATE533744T1 (de) N-benzoypyrrolidin-3-ylamine als histamin-3 antagonisten
ATE530650T1 (de) Hochaffine antagonisten von elr-cxc-chemokinen

Legal Events

Date Code Title Description
B08F Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette]

Free format text: REFERENTE A 7A ANUIDADE.

B08K Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette]

Free format text: EM VIRTUDE DO ARQUIVAMENTO PUBLICADO NA RPI 2329 DE 25-08-2015 E CONSIDERANDO AUSENCIA DE MANIFESTACAO DENTRO DOS PRAZOS LEGAIS, INFORMO QUE CABE SER MANTIDO O ARQUIVAMENTO DO PEDIDO DE PATENTE, CONFORME O DISPOSTO NO ARTIGO 12, DA RESOLUCAO 113/2013.